Clinical cohort study on prevention and treatment of coronary heart disease in Beijing-Tianjin-Hebei region

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100045881

Enrollment

Unknown

Registered

2021-04-25

Start date

2021-06-01

Completion date

Unknown

Last updated

2021-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronary heart disease

Interventions

case series:None

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients diagnosed with coronary heart disease in previous or current hospitalization; 2. Living in Beijing-Tianjin-Hebei area > 5 years; 3. Aged 18 to 80 years.

Exclusion criteria

Exclusion criteria: 1. Patients with severe liver and kidney dysfunction; 2. Patients with malignant tumors found in the previous or first diagnosis; 3. Severe cardiac valvular disease; 4. Dilated or hypertrophic cardiomyopathy; 5. Complicated with anemia or infection-related diseases.

Design outcomes

Primary

Measure	Time frame
Tumor necrosis factor alpha (TNF-a);Interleukin 8 (IL-8);Interleukin 1ß (IL-1ß);Serum C reactive protein;Hamilton Anxiety and Depression Scale;PSQI;Ventricular premature beats;	—

Countries

China

Contacts

Public ContactLiu Gang

The First Hospital of Hebei Medical University

cardio2004@163.com+86 18633889897

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026